{
    "Trade/Device Name(s)": [
        "Gold Standard Diagnostics Borrelia burgdorferi VlsE-OspC IgG/IgM ELISA Test Kit"
    ],
    "Submitter Information": "Gold Standard Diagnostics",
    "510(k) Number": "K203289",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "November 4, 2020",
    "Summary Letter Received Date": "November 9, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "Borrelia burgdorferi VlsE",
        "Borrelia burgdorferi OspC",
        "IgG",
        "IgM"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Gold Standard Diagnostics Borrelia burgdorferi VlsE-OspC IgG/IgM ELISA Test Kit for detection of Lyme disease antibodies in human serum",
    "Indications for Use Summary": "For qualitative detection of IgG and IgM class antibodies to Borrelia burgdorferi VlsE and OspC antigens in human serum from symptomatic patients or those suspected of having Lyme disease, as part of first-tier testing in standard or modified two-tier methodologies.",
    "fda_folder": "Microbiology"
}